Last edition
News about
MHRA and FDA Partner to Fast-Track Innovative Medical Devices for Patients
The Medicines and Healthcare products Regulatory Agency (MHRA) is strengthening its collaboration with the US Food and Drug Administration (FDA) to accelerate patient access to safe and innovative medical technologies in both the United Kingdom and the United States.
India Pharma 2026 to Spotlight Innovation-Driven Growth in Life Sciences
The Department of Pharmaceuticals (DoP), in collaboration with Federation of Indian Chambers of Commerce & Industry (FICCI) and Indian Pharmaceutical Alliance, will host the 9th edition of India Pharma 2026 on April 13–14, 2026, at Federation House, New Delhi.
NIH Scientists Discover Safer, Highly Potent Opioid with Potential for Pain and Addiction Treatment
A newly discovered opioid compound by NIH researchers shows strong pain relief without typical addiction risks, marking a potential breakthrough in safer pain management therapies.
Glenmark Takes Charge of RYALTRIS Commercialisation in US
Glenmark will handle end-to-end commercialisation and distribution of RYALTRIS nasal spray in the US, strengthening its respiratory portfolio presence.
Symbiosis Expands QC Capabilities with New Stability Chamber to Support Global Drug Supply
Symbiosis enhances its quality control lab with a new stability chamber, enabling comprehensive climate-based testing for global distribution of injectable drug products.
Syneron Bio Raises USD 150 Million in Series B Funding
Syneron Bio raises USD 150 million in Series B to advance its Synova macrocyclic peptide platform and accelerate pipeline development towards clinical stages.
Indian Pharma Faces Limited Impact from US Tariffs on Patented Medicines
The announcement by Donald J Trump to impose a 100 Percent tariff on patented pharmaceuticals and their ingredients is expected to have a limited immediate impact on the Indian pharmaceutical industry, according to industry experts.
TechBio Startup Generare Raises 20 Million Euros to Unlock Novel Drug Discovery Data
Generare, a techbio company focused on generating novel molecular data for drug discovery, has raised 20 million euros in a Series A funding round co-led by Alven and Daphni, with participation from existing investors including Galion.exe, Teampact Ventures and VIVES Partners.
Imfinzi Combo Improves PFS in Unresectable Liver Cancer in Phase 3 EMERALD-3 Trial
Imfinzi-based combination improves progression-free survival and shows a trend towards overall survival benefit in unresectable liver cancer in the Phase 3 EMERALD-3 trial.
Aspect Biosystems Secures USD 280 Million Canada Partnership for Bioengineered Cell Therapies
Aspect Biosystems secures USD 280 Million partnership with Canada to advance bioengineered cell therapies, accelerating clinical development and expanding biomanufacturing capabilities.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy